Top Section
Opinion: TMK’s treaty exit – London’s fading reinsurance star grows a little dimmer
The former reinsurance leader’s exit from treaty highlights wider pressures on the market.
Latest News
The Corporation has resequenced a key Blueprint workstream for delegated authority business, as it looks to create a data strategy for DA in Q4.
George Green has been a war and terrorism underwriter at Fidelis since March 2021.
The executive replaces Rob Forster, who was holding the role on an interim basis.
In an open letter, the asset manager said investors had seen the performance of the business deteriorate under the leadership of William Spiegel.
Opinion
Opinion
Ukraine reserving at Q2: Mind the gap
The Ukraine loss reserve tally has reached $2.4bn as of the end of June.
Most Read
-
Harrell's incubator buys stakes in two firms with Rcapital
16 August 2022
Analysis
Swiss Re, Munich Re, Hannover Re and Scor have set out their strategies on inflation, pricing and Ukraine.
The first six months have been characterised by substantial double-digit growth and further improvement in underwriting performance.
Carriers in the class are reassessing risk appetites amid inflation, the Ukraine war and a growing risk of countries defaulting on sovereign debt.
The market is concerned about potential claims from the Hellenic War Risks mutual, which has ships worth around $350mn stuck in the Black Sea.
More News
-
Brickell backs calls to remove Spiegel from R&Q board
16 August 2022 -
Enstar boosts position in Argo to 4.9% amid sale process
15 August 2022 -
Chubb adds Nexus’ Audis to aviation team
15 August 2022
-
Brazilian reinsurer IRB Re explores fundraise
15 August 2022 -
Compre enters European medmal with EUR200mn German LPT deal
15 August 2022
Interviews
Interviews
Investors are beginning to pull back from writing $50mn+ funding cheques for InsurTechs, according to Zach Powell, general partner at Eos Ventures.
The capital provider believes the time is ripe to take on increased underwriting risk.
InsurTechs with diversified teams and deep-rooted technology are more likely to survive the current funding drought, according to MS&AD Ventures’ Jon Soberg.
As partner at major InsurTech investor Anthemis, Ruth Foxe Blader explained to Insurance Insider why venture capitalists are pumping the brakes on InsurTech funding.
Upcoming Events
From our other titles
More from our other titles
From Inside P&C
Lemonade & Root Q2: Low-Fidelity
The InsurTechs’ results show the path to profitability remains unclear, even as Lemonade said it expects to be self-funding from here.
From Trading Risk
ILS adjusts its stride to adapt to higher inflation
The industry is sharpening its exposure forecasting capabilities in response to investor demand.
From Inside P&C
Allstate Q2: A deeper dive into auto body repair, rates, and loss cost trends
The personal lines insurer’s results were also impacted by the states’ regulatory climates and inflationary trends.
From Insider Engage
‘Obfuscated’ Social Inflation Illuminated Again as Insurers Fight Back
A pandemic reprieve has given way to mounting concern about mammoth jury awards.
